Literature DB >> 11246148

Hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus and the effects of pretreatment with haloperidol and clozapine.

T Bast1, W N Zhang, C Heidbreder, J Feldon.   

Abstract

This study re-examined the hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the rat ventral hippocampus and compared how both effects were affected by pretreatment with either haloperidol or clozapine. While the hyperactivity is thought to depend on dopamine receptor activation in the nucleus accumbens, the dopamine D2-class receptor blocker haloperidol failed to antagonize the disruption of prepulse inhibition in previous studies. However, an ameliorative effect of the atypical neuroleptic clozapine on disruption of prepulse inhibition was suggested by our previous experiments [Zhang et al. (1999) NeuroReport 10, 1-6]. In the present study, bilateral infusion of N-methyl-D-aspartate (0.5microg/side) into the ventral hippocampus of Wistar rats increased open field locomotor activity and disrupted prepulse inhibition. Both effects were observed immediately after infusion but disappeared 24h later. Injection of haloperidol (0.2mg/kg) or clozapine (5mg/kg), 45min prior to N-methyl-D-aspartate infusion, totally antagonized the hyperactivity but did not affect the disruption of prepulse inhibition. We conclude that dopaminergic mechanisms are differentially involved in the hyperactivity and disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus. Activation of accumbal dopamine receptors, which is blocked by clozapine and haloperidol to a comparable extent, seems to be crucial for the hyperactivity but not the disruption of prepulse inhibition. The present finding that both clozapine and haloperidol failed to antagonize the disruption of prepulse inhibition induced by N-methyl-D-aspartate stimulation of the ventral hippocampus is discussed with respect to our previous contrary finding concerning the ameliorative effect of clozapine and with respect to the disruption of prepulse inhibition in rats being considered as a model of sensorimotor gating deficits in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246148     DOI: 10.1016/s0306-4522(00)00589-3

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  18 in total

1.  Modulation of sensorimotor gating in prepulse inhibition by conditional brain glycine transporter 1 deletion in mice.

Authors:  Philipp Singer; Detlev Boison; Hanns Möhler; Joram Feldon; Benjamin K Yee
Journal:  Eur Neuropsychopharmacol       Date:  2010-07-19       Impact factor: 4.600

2.  The GABAA receptor-mediated recurrent inhibition in ventral compared with dorsal CA1 hippocampal region is weaker, decays faster and lasts less.

Authors:  Theodoros Petrides; Panagiotis Georgopoulos; George Kostopoulos; Costas Papatheodoropoulos
Journal:  Exp Brain Res       Date:  2007-03       Impact factor: 1.972

3.  Corresponding decrease in neuronal markers signals progressive parvalbumin neuron loss in MAM schizophrenia model.

Authors:  Kathryn M Gill; Anthony A Grace
Journal:  Int J Neuropsychopharmacol       Date:  2014-04-30       Impact factor: 5.176

4.  Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia.

Authors:  Robin Nguyen; Mark D Morrissey; Vivek Mahadevan; Janine D Cajanding; Melanie A Woodin; John S Yeomans; Kaori Takehara-Nishiuchi; Jun Chul Kim
Journal:  J Neurosci       Date:  2014-11-05       Impact factor: 6.167

5.  Schizophrenia-like reduced sensorimotor gating in intact inbred and outbred rats is associated with decreased medial prefrontal cortex activity and volume.

Authors:  Carles Tapias-Espinosa; Cristóbal Río-Álamos; Ana Sánchez-González; Ignasi Oliveras; Daniel Sampedro-Viana; Maria Del Mar Castillo-Ruiz; Toni Cañete; Adolf Tobeña; Alberto Fernández-Teruel
Journal:  Neuropsychopharmacology       Date:  2019-04-16       Impact factor: 7.853

6.  Prefrontal D1 and ventral hippocampal N-methyl-D-aspartate regulation of startle gating in rats.

Authors:  J M Shoemaker; R L Saint Marie; M J Bongiovanni; A C Neary; L S Tochen; N R Swerdlow
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

Review 7.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

8.  Neurobehavioral abnormalities in the dysbindin-1 mutant, sandy, on a C57BL/6J genetic background.

Authors:  M M Cox; A M Tucker; J Tang; K Talbot; D C Richer; L Yeh; S E Arnold
Journal:  Genes Brain Behav       Date:  2009-02-11       Impact factor: 3.449

9.  Pathways from the ventral hippocampus and caudal amygdala to forebrain regions that regulate sensorimotor gating in the rat.

Authors:  E J Miller; L R Saint Marie; M R Breier; N R Swerdlow
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

10.  Acute or subchronic clozapine treatment does not ameliorate prepulse inhibition (PPI) deficits in CPB-K mice with low levels of hippocampal NMDA receptor density.

Authors:  Rainer Wolf; Katrin Paelchen; Kay Matzke; Henrik Dobrowolny; Bernhard Bogerts; Herbert Schwegler
Journal:  Psychopharmacology (Berl)       Date:  2007-05-31       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.